Clinical Trial Update: A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia [Phase 3]

View source ↗

Summary

Phase III clinical trial evaluating the efficacy and safety of HSK3486 for sedation or anesthesia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sedation or Anesthesia

Drugs mentioned

• HSK3486 (HSK3486)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Sedation or Anesthesia | Phase 3 | Status: COMPLETED